Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1981 1
1982 1
1983 3
1985 1
1986 3
1989 4
1990 3
1991 1
1992 7
1993 6
1994 3
1995 6
1996 9
1997 6
1998 6
1999 11
2000 10
2001 16
2002 19
2003 15
2004 12
2005 7
2006 25
2007 30
2008 16
2009 29
2010 38
2011 29
2012 30
2013 25
2014 39
2015 31
2016 33
2017 27
2018 35
2019 37
2020 39
2021 26
Text availability
Article attribute
Article type
Publication date

Search Results

587 results
Results by year
Filters applied: . Clear all
Page 1
Ultra-processed foods: what they are and how to identify them.
Monteiro CA, Cannon G, Levy RB, Moubarac JC, Louzada ML, Rauber F, Khandpur N, Cediel G, Neri D, Martinez-Steele E, Baraldi LG, Jaime PC. Monteiro CA, et al. Among authors: neri d. Public Health Nutr. 2019 Apr;22(5):936-941. doi: 10.1017/S1368980018003762. Epub 2019 Feb 12. Public Health Nutr. 2019. PMID: 30744710
Ubiquitin Phosphorylation at Thr12 Modulates the DNA Damage Response.
Walser F, Mulder MPC, Bragantini B, Burger S, Gubser T, Gatti M, Botuyan MV, Villa A, Altmeyer M, Neri D, Ovaa H, Mer G, Penengo L. Walser F, et al. Among authors: neri d. Mol Cell. 2020 Nov 5;80(3):423-436.e9. doi: 10.1016/j.molcel.2020.09.017. Epub 2020 Oct 5. Mol Cell. 2020. PMID: 33022275
Reflections on DNA-encoded chemical libraries.
Lerner RA, Neri D. Lerner RA, et al. Among authors: neri d. Biochem Biophys Res Commun. 2020 Jun 30;527(3):757-759. doi: 10.1016/j.bbrc.2020.04.080. Epub 2020 May 18. Biochem Biophys Res Commun. 2020. PMID: 32439178
Special edition on DNA-Encoded chemical libraries.
Scheuermann J, Neri D. Scheuermann J, et al. Among authors: neri d. Biochem Biophys Res Commun. 2020 Dec 3;533(2):iii-iv. doi: 10.1016/j.bbrc.2020.10.055. Biochem Biophys Res Commun. 2020. PMID: 33131653 No abstract available.
Stereotactic ablative body radiotherapy (SABR) combined with immunotherapy (L19-IL2) versus standard of care in stage IV NSCLC patients, ImmunoSABR: a multicentre, randomised controlled open-label phase II trial.
Lieverse RIY, Van Limbergen EJ, Oberije CJG, Troost EGC, Hadrup SR, Dingemans AC, Hendriks LEL, Eckert F, Hiley C, Dooms C, Lievens Y, de Jong MC, Bussink J, Geets X, Valentini V, Elia G, Neri D, Billiet C, Abdollahi A, Pasquier D, Boisselier P, Yaromina A, De Ruysscher D, Dubois LJ, Lambin P. Lieverse RIY, et al. Among authors: neri d. BMC Cancer. 2020 Jun 15;20(1):557. doi: 10.1186/s12885-020-07055-1. BMC Cancer. 2020. PMID: 32539805 Free PMC article.
587 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page